"Dermatologic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs used to treat or prevent skin disorders or for the routine care of skin.
| Descriptor ID |
D003879
|
| MeSH Number(s) |
D27.505.954.444
|
| Concept/Terms |
Dermatologic Agents- Dermatologic Agents
- Dermatological Agents
- Agents, Dermatological
- Agents, Dermatologic
- Dermatologic Agent
- Agent, Dermatologic
- Agent, Dermatological
- Dermatological Agent
|
Below are MeSH descriptors whose meaning is more general than "Dermatologic Agents".
Below are MeSH descriptors whose meaning is more specific than "Dermatologic Agents".
This graph shows the total number of publications written about "Dermatologic Agents" by people in this website by year, and whether "Dermatologic Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 1 | 0 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 2 | 0 | 2 |
| 2011 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2014 | 2 | 0 | 2 |
| 2016 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 0 | 1 | 1 |
| 2021 | 1 | 1 | 2 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dermatologic Agents" by people in Profiles.
-
Patel D, Svoboda R, Maczuga S, Foulke GT, Helm M. A retrospective claims analysis confirms the cost of most biologic agents for psoriasis is increasing more rapidly than medical inflation. J Am Acad Dermatol. 2023 02; 88(2):490-493.
-
Katz EL, Harris JE. Translational Research in Vitiligo. Front Immunol. 2021; 12:624517.
-
Guo W, Zhu C, Stevens G, Silverstein D. Analyzing the Efficacy of Isotretinoin in Treating Dissecting Cellulitis: A Literature Review and Meta-Analysis. Drugs R D. 2021 Mar; 21(1):29-37.
-
Franciosi E, Blankenship K, Houk L, Rashighi M. Ovoid palatal patch: a clue to anti-TIF1? dermatomyositis. BMJ Case Rep. 2020 Apr 23; 13(4).
-
Van Voorhees AS, Mason MA, Harrold LR, Guo N, Guana A, Tian H, Herrera V, Strober BE. Characterization of insufficient responders to anti-tumor necrosis factor therapies in patients with moderate to severe psoriasis: real-world data from the US Corrona Psoriasis Registry. J Dermatolog Treat. 2021 May; 32(3):302-309.
-
Bronckers IMGJ, Seyger MMB, West DP, Lara-Corrales I, Tollefson M, Tom WL, Hogeling M, Belazarian L, Zachariae C, Mah? E, Siegfried E, Philipp S, Szalai Z, Vleugels RA, Holland K, Murphy R, Baselga E, Cordoro K, Lambert J, Alexopoulos A, Mrowietz U, Kievit W, Paller AS. Safety of Systemic Agents for the Treatment of Pediatric Psoriasis. JAMA Dermatol. 2017 11 01; 153(11):1147-1157.
-
Albrecht J, Lebwohl M, Asgari MM, Bennett DD, Cook A, Evans CC, Green LJ, Hodge JA, Kourosh AS, Maloney ME, Howard LM, Olsen EA, Rosenberg SP, Rubin A, Stough DB, Taylor SC, Brod BA. The state and consequences of dermatology drug prices in the United States. J Am Acad Dermatol. 2016 Sep; 75(3):603-605.
-
Feely MA, Smith BL, Weinberg JM. Novel psoriasis therapies and patient outcomes, part 1: topical medications. Cutis. 2015 Mar; 95(3):164-8, 170.
-
V?lez NF, Jellinek NJ. Simple onycholysis: a diagnosis of exclusion. J Am Acad Dermatol. 2014 Apr; 70(4):793-794.
-
Klunk C, Domingues E, Wiss K. An update on diaper dermatitis. Clin Dermatol. 2014 Jul-Aug; 32(4):477-87.